Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Musculoskeletal  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Parkinson's Disease Clinical Trials

A listing of Parkinson's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (609) clinical trials

To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) extended-release capsules (IPX203 ER CD-LD) in comparison to immediate release (IR) CD-LD in the treatment of CD-LD-experienced subjects with Parkinson's disease (PD) who have motor fluctuations.  

Phase

People with Parkinson's Disease Dementia are asked to participate in a research study being conducted by New York University School of Medicine.

Effectiveness of study drug  LY3154207 on cognition and memory in person's with Mild to Moderate Parkinson's Disease Dementia (PDD)  

Phase

A 24-week, prospective, multi-center, open-label, Phase 3 study in L-Dopa responsive PD patients with motor fluctuations ("OFF" episodes), designed to evaluate the long-term safety, tolerability and efficacy of APL-130277.  

Phase

A Phase 3, Twelve-week, Multi-Center, Multinational, Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Determine the Efficacy, Safety and Tolerability of P2B001 Once Daily Compared to its Individual Components in Subjects With Early Parkinson's Disease and to a Calibration Arm of Pramipexole ER.  

Phase

A study to evaluate the safety and tolerability of SEP363856 in subjects with Parkinson's Disease Psychosis.  

Phase

This is a randomized placebo-controlled trial in individuals with Parkinson's disease dementia to evaluate the safety and efficacy of three doses of a study drug in participants with mild-to-moderate Parkinson's disease dementia treated for 12 weeks.  

Phase

Subjects stable on L-Dopa and oral ropinirole will have their ropinirole replaced with the Ropinirole Implant(s). The Ropinirole Implant was designed using the ProNeura™ implant technology where the implant is inserted under the skin. This study will measure how much ropinirole is released in the blood during 3 months of dosing, and evaluate ...

Phase

Alpha-synuclein (a-syn) is a protein and a major component of Parkinson’s Disease (PD). The purpose of this study is to determine the kinetics (half-life or how quickly a-syn is cleared from the body), we will use 3 proven approaches to determine this. 10 days of oral-labeling followed by 5 subsequent LPs ...

Phase N/A